Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.5.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.5.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBDORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBDENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBDNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EB.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CN.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CN.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CN.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BG.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BG.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BG.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.576ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.576ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.576ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.576NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.325ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.325ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.325ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.325NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.521ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.521ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.521ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.521NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used